Europe
For the past 20 years, Novartis has held a 33% stake in Roche, its Basel, Switzerland neighbor. Now, Novartis has divested its one-third stake to Roche for a whopping $20.7 billion.
Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.
In November 2019, Emory realized this experimental drug could have significant potential in respiratory viruses such as COVID-19.
This novel diagnostic technology uses augmented reality and a smartphone or tablet to administer cognitive and functional tests.
The acquisition of the medicines – which netted AstraZeneca $143 million in the geographies covered under the agreement – provides a significant boost to Covis’s respiratory portfolio.
GlaxoSmithKline denied reports that they were interested in acquiring Canada’s Aurinia Pharmaceuticals, although some reports claim they are preparing to bid.
As the world marks a grim milestone of 5 million COVID-19 deaths, public health officials are keeping a close watch on a substrain of the Delta variant.
Yet another busy week for clinical trial news. Here’s a look.
The life sciences industry continues to be one of the fastest growing industries in the world as the end of the year draws near.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
PRESS RELEASES